Jan-Feb 2008
N-Sulfinyl Dienophiles for Asymmetric Hetero-Diels-Alder Reactions
153
was added. The resulting mixture was stirred for 10 min before a
precooled solution of 1,3-cyclohexadiene (2) (0.80 mmol) in dry
CH2Cl2 (0.5 ml) was added slowly along the wall of the flask.
After 22 hours reaction time, the reaction mixture was quenched
by addition of a phosphate buffer (pH 7, 3 ml), allowed to warm
to room temperature, and worked up as described in general
procedure A.
Asymmetric HDA Reaction with 100 mol % of 5-TiCl2.
The 5-TiCl2 promoted HDA reactions were performed as
described in the literature [1d].
5.3 Hz), 120.4(d, JPC = 5.4 Hz), 60.1 (C-4), 46.9 (C-1), 28.6 (d,
JPC = 3.9 Hz, C-6), 21.1 (C-5); ms: (70 eV, electron impact) m/z
326 (33), 275 (4.6), 250 (57.9), 249 (100), 248 (66.1), 232
(13.9), 218 (10.4), 170 (65.6), 156 (23.3), 126 (14.7), 110 (25.1),
94 (93.6), 78 (89.1), 77 (97.7), 65 (24.5), 51 (24.3). Anal. Calcd
for C24H24NO4PS; C, 63.56; H, 5.33; N, 3.09. Found: C, 63.25;
H, 5.36; N, 2.97. The absolute configuration of [1R,4S,S(S)]-6
was determined by X-ray crystallographic analysis (Figure 2)
[8].
3-(5-Methylisoxazol-3-yl)-2ꢀ4-thia-3-azabicyclo[2.2.2]oct-5-
ene 2-oxide (3d). The uncatalysed reaction between N-sulfine
1d and 2 according to the general procedure afforded a mixture
of endo-3d and exo-3d (2:1). Flash chromatography (EtOAc/
hexane 4/1) of the crude product yielded 259 mg (64% yield) of
endo-3d as a white solid and second fraction containing a
mixture of 5-methyl-3-isoxazolamine and exo-3d. All attempts
to separate 5-methyl-3-isoxazolamine and exo-3d failed.
Analytical data for endo-3d: Tlc Rf 0.15 (EtOAc/hexane 4/1);
mp 126-127 °C; ir (potassium bromide): 3130 (w), 2963 (w),
1616 (s), 1485 (s), 1455 (s), 1433 (s), 1367 (s), 1273 (s), 1163
(s), 1102 (s), 1045 (s), 1009 (s) cm-1; 1H nmr: ꢀ 7.00 (1H, ddd, J
= 7.9, 7.1, 1.5 Hz, H-5), 6.35 (1H, app t, J = 7.49, 7.27 Hz, H-6),
6.02 (1H, s, 4-isoxozol), 5.12-5.09 (1H, m, H-4), 4.35-4.31(1H,
m, H-1), 2.36 (3H, s, CH3), 2.05-1.94 (1H, m, H-8), 1.87-1.79
(1H, m, H-7), 1.58-1.51 (1H, m, H-8), 1.31-1.23 (1H, m, H-7);
13C nmr: ꢀ 170.3 (5-isoxazol), 162.5 (3-isoxazol), 137.6 (C-5),
125.2 (C-6), 94.4 (4-isoxazol), 55.4 (C-1), 50.8 (C-4), 22.4 (C-
8), 15.9 (C-7), 12.8 (CH3); ms: (70 eV, electron impact) m/z 224
(M+, 0.1), 163 (2), 146 (9), 144 (134), 109 (18), 80 (82), 79
(100). Anal. Calcd for C10H12N2O2S: C, 53.55; H, 5.39; N, 12.49;
S, 14.30. Found: C, 53.31; H, 5.43; N, 12.43; S, 14.45. The
relative configuration of (1R*,2S*,4S*)-3d was determined by
X-ray crystallographic analysis (Figure 3) [8]. Data for exo-3d:
(1S,2R,4R)-(2-Oxo-2ꢀ4-thia-3-azabicyclo[2.2.2]oct-5-en-3-
yl)phosphonic acid diphenyl ester ((1S,2R,4R)-3c).
Asymmetric HDA reaction between 1c and 2, catalysed by 4-
Cu(OTf)2 or 4-Zn(OTf)2 according to the general procedures A
and B, afforded only the endo adduct (1S,2R,4R)-3c in 46 – 97%
ee and in 51 – 73% yields (Table 1, entries 2 - 7) as a white
solid. The crude product was in general purified by flash
chromatography (EtOAc/pentane 1/1). Analytical data for
(1S,2R,4R)-3c: Tlc Rf 0.16 (EtOAc/pentane 1/1); mp 101-103
°C; [ꢀ]2D0 -163.5 (c = 1.0, CH2Cl2); hplc: (Chiralpak AD, 2-
propanol/n-hexane 20/80, 1 ml min-1, 230 nm) 88% ee, tR 22.84
(1R,2S,4S) and 27.77 (1S,2R,4R) min; ir (potassium bromide):
3241 (w), 3058 (w), 2967 (w), 1586 (s), 1487 (s), 1373 (s), 1283
(m), 1234 (m) cm-1; 1H nmr: ꢀ 7.38-7.23 (10H, m, Ph), 6.86 (1H,
app t, J = 7.55, 7.45 Hz, H-5), 6.28 (1H, app t, J = 7.4 Hz, H-6),
4.88-4.82 (1H, m, H-4), 4.38-4.32 (1H, m, H-1), 1.80-1.60 (2H,
m, H-7/H-8), 1.48-1.35 (1H, m, H-8), 1.20-1.07 (1H, m, H-7);
13C nmr: ꢀ 150.6 (d, JPC = 4.02 Hz), 150.5 (d, JPC = 4.02 Hz),
137.2 (d, JPC = 5.01 Hz, C-5), 130.0, 129.9, 125.7, 125.6 (d, JPC
= 3.02 Hz, C-6), 120.6 (d, JPC = 5.03 Hz), 120.5 (d, JPC = 5.03
Hz), 56.1 (d, JPC = 5.03 Hz, C-1), 50.9 (d, JPC = 2.01 Hz, C-4),
24.6 (C-7), 14.9 (C-8); ms: (70 eV, electron impact) m/z 375
(0.1, M+), 329 (3), 295 (47), 247 (67), 246 (63), 201 (8), 170
(50), 156 (19), 94 (44), 77 (96), 65 (29), 51 (29). Anal. Calcd for
C18H18NO4PS: C, 57.59; H, 4.83; N, 3.73. Found: C, 57.66; H,
4.81; N, 3.81.
1
Tlc Rf 0.31 (EtOAc/hexane 4/1); H nmr: ꢀ (selected signals)
6.98 (1H, ddd, J = 8.2, 5.8, 1.0 Hz, H-5), 6.30 (1H, app t, J = 7.6
Hz, H-6), 5.95 (1H, s, 4-isoxazol), 5.00-4.97 (1H, m, H-4), 4.13-
4.07 (1H, m, H-1), 2.91-2.85 (1H, m, H-7), 2.34 (3H, s, CH3),
2.44-2.38 (1H, m, H-8), 1.64-1.51 (2H, m, H-7/8); 13C nmr:
170.6 (5-isoxazol), 162.4 (3-isoxazol), 141.4 (C-5), 127.5 (C-6),
94.4 (4-isoxazol), 56.0 (C-1), 50.5 (C-4), 24.7 (C-7), 12.7 (CH3),
11.4 (C-8).
The asymmetric HDA reaction between 1d and 2, promoted
by 4-Zn(OTf)2 according to the general procedure B, afforded
exclusively endo-3d as product (Table 1, entry 9). Analytical
data: [ꢀ]2D0 -230.2 (c = 1.0, CH2Cl2); hplc: (Chiralcel OJ, 2-
propanol/n-hexane 35/65, 0.5 ml min-1, 230 nm) 68% ee, tR
23.69 and 30.59 (major) min. The absolute configuration was
not determined.
[1R,4S,S(S)]-(4-Benzenesulfinylcyclohex-2-enyl)phosphor-
amidic acid diphenyl ester, [1R,4S,S(S)]-6. A solution of
phenyl magnesium bromide in THF (1 M, 604 μl, 0.604 mmol)
was added to a stirred solution of (1S,2R,4R)-3c (88% ee, 201
mg, 0.537 mmol) in dry THF (4 ml) at -60 °C and the mixture
was stirred for 30 min and then hydrolyzed with aqueous NH4Cl
(satd. 8 ml). The layers were separated and the aqueous layer
extracted with Et2O (3 x 4 ml). The combined organics were
washed with brine (5 ml), dried (MgSO4) and concentrated in
vacuo. The crude was purified by flash chromatography
(EtOAc/pentane, gradient 1/1 to 7/3) yielded the allylic
sulfoxide [1R,4S,S(S)]-6 (192.4 mg, 79%) as a white solid.
Analytical data for [1R,4S,S(S)]-6: Mp 140-141 °C (from
CH2Cl2/heptane); [ꢀ]2D0 -222 (c = 1.0, CH2Cl2); hplc: (Chiralpak
AD, 2-propanol/n-hexane 40/60, 1 ml min-1, 230 nm) 77% ee, tR
13.47 [1S,4R,S(R)] and 21.06 [1R,4S,S(S)] min.); ir (potassium
bromide): 3193 (w), 2918 (w), 1589 (m), 1483 (s), 1251 (m),
3-(2-Pyrimidinyl)-2ꢀ4-thia-3-azabicyclo[2.2.2]oct-5-ene 2-
oxide (3e). The uncatalysed reaction between N-sulfine 1e and 2
according to the general procedure afforded a mixture of endo-
3e and exo-3e (1:4). Flash chromatography (EtOAc/hexane 4/1)
of the crude product yielded 155 mg (51% yield) of exo-3e as a
white solid and a second fraction containing a mixture of endo-
3e and 2-pyrimidinamine. Flash chromatography (acetone
/CH2Cl2 1/9) of the latter fraction afforded 43 mg (14% yield) of
endo-3e as a white solid. Analytical data of endo-3e: Tlc Rf 0.13
(EtOAc/hexane 4/1); mp 126-127 °C; ir (potassium bromide):
3074 (w), 2939 (w), 1578 (s), 1556 (s), 1416 (s), 1370 (m), 1349
1
1194 (s) cm-1; H nmr: ꢀ 7.60-7.54 (2H, m, Ph) 7.46-7.43 (3H,
m, Ph), 7.40-7.30 (4H, m, Ph), 7.28-7.21 (4H, m, Ph), 7.20-7.13
(2H, m, Ph), 6.07 (1H, ddd, J = 10.1, 3.4, 1.7 Hz, H-2), 5.50
(1H, ddd, J = 10.1, 3.4, 1.5 Hz, H-3), 3.95 (1H, m, H-1), 3.30
(1H, m, H-4), 3.20 (1H, t, J = 11.6 Hz, NH), 2.12-2.0 (1H, m, H-
5), 1.95-1.84 (1H, m, H-5), 1.83-1.70 (1H, m, H-6), 1.68-1.55
(1H, m, H-6); 13C nmr: ꢀ 151.0 (d, JPC = 4.5 Hz), 150.91 (d, JPC
= 4.5 Hz), 141.9, 137.5 (d, JPC = 6.64 Hz, C-2), 131.4, 129.9,
1
(m), 1109 (m) cm-1; H nmr: ꢀ 8.48 (2H, d, J = 4.8 Hz, 4-pyr/6-
pyr), 7.00 (1H, ddd, J = 8.1, 7.2, 1.6 Hz, H-5), 6.84 (1H, t, J =
4.8 Hz, 5-pyr), 6.44 (1H, app t, J = 7.2 Hz, H-6), 5.75-5.72 (1H,
129.2, 125.2 (app. d, JPC = 2.9 Hz), 124.8, 121.9, 120.5 (d, JPC
=